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Heme plays fundamental roles as cofactor and
signaling molecule in multiple pathways devoted to
oxygen sensing and utilization in aerobic organisms.
For cellular respiration, heme serves as a prosthetic
group in electron transfer proteins and redox
enzymes. Here we report that in the yeast Saccharo-
myces cerevisiae, a heme-sensingmechanism trans-
lationally controls the biogenesis of cytochrome c
oxidase (COX), the terminal mitochondrial respira-
tory chain enzyme. We show that Mss51, a COX1
mRNA-specific translational activator and Cox1
chaperone, which coordinates Cox1 synthesis in
mitoribosomes with its assembly in COX, is a
heme-binding protein. Mss51 contains two heme
regulatory motifs or Cys-Pro-X domains located in
its N terminus. Using a combination of in vitro and
in vivo approaches, we have demonstrated that
these motifs are important for heme binding and effi-
cient performance of Mss51 functions. We conclude
that heme sensing by Mss51 regulates COX biogen-
esis and aerobic energy production.
INTRODUCTION
Heme (iron protoporphyrin IX) plays essential roles in pathways
devoted to oxygen sensing, transport, and utilization in aerobic
organisms (Mense and Zhang, 2006), including the generation
of cellular energy in the form of ATP by themitochondrial electron
transport chain (ETC) and the oxidative phosphorylation
(OXPHOS) system. Several hemes with different chemical struc-
ture (hemes B, C, and A) are embedded in the components form-
ing the ETC (Kim et al., 2012). Cytochrome c oxidase (COX), the
single-cellular enzyme that contains heme A, is the terminal ETC
oxidase. COX is the primary site of cellular oxygen consumption
and, as such, is central to OXPHOS and aerobic energy genera-
tion. COX is amitochondrial inner membrane complex formed by
three catalytic core subunits (Cox1, Cox2 and Cox3) encoded in
the mitochondrial DNA (mtDNA) and additional nuclear DNA-Cell Mencoded subunits (at least eight in the yeast Saccharomyces
cerevisiae) that provide stability and protection to the core
(Soto et al., 2012). The catalytic core contains two hememoieties
(a and a3) located in Cox1 and two copper centers, CuA in Cox2
and CuB in Cox1. In Cox1, the heme iron of cytochrome a3
together with CuB constitutes the binding site for oxygen. Four
electrons from ferricytochrome c are sequentially transferred to
CuA, heme a and subsequently to the binuclear heme a3-CuB
center to reduce one O2 molecule to two H2O in a process
involving four one-electron reduction reactions and the pumping
of protons into the mitochondrial intermembrane space to drive
ATP synthesis (Soto et al., 2012).
COX biogenesis is extensively regulated to facilitate the stoi-
chiometric accumulation of its constitutive subunits, the sequen-
tial incorporation of subunits to a Cox1 assembly seed, and the
formation of the metal centers, while minimizing the buildup of
reactive assembly intermediates. In addition to the structural
subunits, a growing list of more than 30 ancillary factors, usually
conserved from yeast to human, assists all the steps of COX
biogenesis (Soto et al., 2012).
Synthesis, membrane insertion, andmaturation of Cox1 deter-
mine the rate of COX assembly. The importance of coordination
of these steps with COX complex formation is highlighted by
the existence in S. cerevisiae of at least two regulatory mecha-
nisms pacing Cox1 synthesis (Barrientos et al., 2004) and hemy-
lation (Barros and Tzagoloff, 2002) to its assembly into COX.
Cox1 synthesis is under the control of a negative feedback
that is depending on the availability of its assembly partners. In
brief, Cox1 synthesis requires two translational activators,
Pet309 and Mss51. Although both interact with the COX1
mRNA 50 untranslated region (UTR) to promote translation,
Mss51 plays additional chaperoning roles by coordinating
Cox1 synthesis and assembly (Barrientos et al., 2004; Perez-
Martinez et al., 2003; Zambrano et al., 2007). During Cox1
synthesis on the mitoribosomes, Mss51 interacts with newly
synthesized Cox1. The translational complex is stabilized by
the COX assembly factors Cox14 (Barrientos et al., 2004) and
Cox25/Coa3 (Fontanesi et al., 2011; Mick et al., 2010). It addi-
tionally contains the mitochondrial Hsp70 chaperone Ssc1 and
its cochaperone Mdj1 (Fontanesi et al., 2010), which could
facilitate the proper folding of Cox1 while it is cotranslationally
inserted into the inner membrane. Subsequently, a 450 kDaetabolism 16, 801–813, December 5, 2012 ª2012 Elsevier Inc. 801
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remains stable until Cox1 proceeds to downstream assembly
steps. This complex, abundant in wild-type cells, represents
a reservoir of stable Cox1 ready to be matured and/or to prog-
ress in the COX assembly process when required.We and others
have postulated that Mss51 interactions within the translational
and preassembly complexes downregulate Cox1 synthesis
when COX assembly is impaired by trapping Mss51 and limiting
its availability for COX1 messenger RNA (mRNA) translation
(Fontanesi et al., 2011; Fontanesi et al., 2010). The C-terminal
residues of Cox1 are essential for Mss51 sequestration and to
stabilize Ssc1-Mss51-Cox14-Cox25/Coa3 interaction (Shingu´-
Va´zquez et al., 2010). According to the translational regulation
model, the release of Mss51-Ssc1 from the preassembly
complex to make Mss51 available for Cox1 synthesis occurs
when Cox1 acquires its prosthetic groups or interacts with other
COX subunits, a step possibly catalyzed by the COX assembly
factors Shy1 and/or Coa1 (Barrientos et al., 2002; Fontanesi
et al., 2008; Mick et al., 2007; Pierrel et al., 2007). When Mss51
is released from the preassembly complex, it forms a stable
120 kDa heterodimeric complex with Ssc1. This complex consti-
tutes a pool of Mss51 that is not involved in Cox1 chaperoning
and may be the source of translationally competent Mss51
(Fontanesi et al., 2010). A second level of regulation of COX
biogenesis implicates heme A, the prosthetic group contained
in the holoenzyme. The biosynthesis of heme A is also controlled
by downstream events in the COX assembly process (Barros
and Tzagoloff, 2002). The connections between heme avail-
ability, heme A biosynthesis and COX1 mRNA translation and
assembly remain to be fully understood.
Heme does not only function as a prosthetic group in proteins
and enzymes but also directly regulates the activity of signal
transducers and transcriptional and translational regulators
involved in oxygen sensing and utilization in bacteria, yeast,
and mammals (Mense and Zhang, 2006). In such proteins,
heme exerts its regulatory function through binding to conserved
heme regulatory motifs (HRM) defined by a cysteine-proline-X
(CPX) sequence. In our search for putative functional domains
in Mss51, we detected the presence of two conserved CPX
motifs located in its N terminus. In the work described here,
we have used in vivo and in vitro approaches to address the
role of the CPX motifs in heme binding to Mss51 and charac-
terize the requirement of heme binding for efficient performance
of Mss51 functions. The identification of a COX1mRNA-specific
translational activator that senses heme provides a key element
for a regulatory mechanism that coordinates assembly of COX
with heme and oxygen availability for respiration and aerobic
energy production.
RESULTS
Recombinant Mss51 Has the Ability to Bind Heme
through CPX Heme Regulatory Motifs
Mss51 is a peripheral mitochondrial inner membrane protein that
faces the matrix. Its N-terminal region contains a hydrophilic
domain that protrudes into the mitochondrial matrix (Zambrano
et al., 2007). By sequence alignments we have identified in this
region the presence of two CPX motifs that are conserved
among fungi (Figure 1A). Because these are potential heme regu-802 Cell Metabolism 16, 801–813, December 5, 2012 ª2012 Elsevierlatory motifs (Mense and Zhang, 2006), we tested whether
Mss51 binds heme in vitro. For this purpose, we purified re-
combinant Mss51 carrying a thrombin-cleavable Escherichia
coli trigger factor N-terminal tag (Mss51-TF) to increase Mss51
solubility and facilitate its purification (Figure S1A available on-
line). The purified protein was subsequently found to specifically
bind hemin-agarose beads (Figure 1B), whereas trigger factor
alone did not (data not shown). Competition assays performed
by preincubation of Mss51 with purified soluble heme species
(heme A or hemin) prior to exposure of the protein to the
hemin-agarose beads showed hemin to be the preferred
in vitro ligand (Figure 1B).
To assess whether heme binding by Mss51 is dependent on
the integrity of the CPX motifs, we purified recombinant
Mss51-TF variants in which cysteine residues from either or
both motifs had been substituted by serines (C85S, C96S, and
C85SC96S) (Figure S1A). The ability of these variants to bind
hemin-agarose beads was severely attenuated when compared
to wild-type Mss51 (>60% of the proteins remained unbound;
Figure 1C), indicating that heme binding to Mss51 in vitro is
mediated by the CPX sequences.
Characterization of theMss51-Heme Interaction In Vitro
Heme binding to Mss51 was monitored by difference UV-visible
spectroscopy as reported (Gupta and Ragsdale, 2011). Binding
equilibrium was achieved within seconds because the Soret
peak maxima absorbance did not increase with longer incuba-
tion times (data not shown). When 50 nM recombinant Mss51
was titratedwith hemin, the difference spectra at pH 8.0 revealed
a Soret band at 416 nm and alpha and beta bands at 550 and
520 nm, respectively. (Figure 1D). This profile is reminiscent of
c-type cytochrome spectra and also hemoprotein spectra in
which iron coordination involves at least one cysteine (Gupta
and Ragsdale, 2011). Mss51 purified in reducing conditions
binds Fe3+ (Figure 1D) and Fe2+ hemin (data not shown) with
a similar affinity (Kd 445 nM). Heme titration with the three
recombinant cysteine variants of Mss51 (C85S, C96S, and
C85SC96S) resulted in several changes in the recorded spectra.
First,we noted a slight shift of theSoret peak (from414or 412nm)
and a significant decrease in its amplitude. Moreover, a diffuse
unresolved broad band in the 525–540 nm region replaced the
550 nm and 520 nm bands (Figure S1B). Such spectral modifica-
tions suggest a heme ligand change in the mutant proteins.
Accordingly, the C85S, C96S, and C85SC96S variants have a
10-fold lower Bmax than wild-type Mss51 (Figure S1B). The C85S
variant binds Fe3+ hemin with affinity (Kd = 0.324 ± 0.074 mM)
similar to the wild-type protein. However, for the C96S and
C85SC96S variants, binding was not strong enough to confi-
dently calculate kinetic parameters.We repeated the experiment
using increased amount of recombinant proteins (150 nM). The
Kd values for the wild-type and C85S proteins were again similar
although slightly higher that when using lower protein concentra-
tion (Figures S1C and S1D). In this assay, the C96S protein
bound hemin with a significantly lower Bmax but apparently
higher affinity than the wild-type, whereas hemin binding by
C85SC96S never reached saturation, suggesting nonspecific
hemin binding (Figures S1C and S1D). These results support
the involvement of the Mss51 CPX motif cysteines in the regula-
tion of heme binding, which is particularly influenced by C96.Inc.
Figure 1. Mss51 Contains Two Conserved CPX Motifs and Binds Heme In Vitro
(A) Partial N-terminal sequence alignment of Mss51 from 12 fungal species. Sequences were aligned with the CLUSTALW algorithm (Blosum62 scoring matrix) in
Bioedit software. Amino acids that are conserved in all sequences are shaded red, and those conserved in at least 9 of 12 sequences are shaded blue. The
conservation of two cysteines in the CPX motifs is marked in yellow. In the linear graph of the protein, all the cysteines (red), and other relevant residues for this
study (green or black) are indicated.
(B andC) Immunoblot analyses of the binding to hemin-agarose beads of recombinant wild-typeMss51 (B) or CPXmutantMss51 (C). Mss51was preincubated or
not with the indicated concentrations of either hemin or heme A prior to incubation with the beads. For quantification of the signals, the images were digitalized
and densitometric analyses performed with the histogram function of the Adobe Photoshop program. The graph represents the proportion of bound versus
unbound protein for each sample. B, bound; U, unbound; P, protein alone.
(D) Difference spectroscopy titration of heme binding to Mss51. Difference absorption spectra and titration curves of wild-type Mss51 (50 nM) with increasing
concentrations of Fe3+ hemin (from 0 to 10 mM) as indicated. The curves were generated from fits to an equation describing a single binding site
(Y =BmaxX=Kd +X) with GraphPad Prism.
(E) Analyses of Mss51 and heme-bound-Mss51 by SDS-PAGE and Native-PAGE. The upper panel represents immunoblot analyses with an anti-Mss51 antibody.
The lower panel represents in gel heme staining.
See also Figures S1 and S6.
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separated the hemin-reconstituted recombinant wild-type
protein in parallel by SDS-PAGE and Native-PAGE and analyzedCell Mit by immunoblotting and in-gel heme staining. In native condi-
tions, only the heme-bound protein entered the gel andmigrated
properly as detected by immunoblotting (Figure 1E). Thisetabolism 16, 801–813, December 5, 2012 ª2012 Elsevier Inc. 803
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oligomerizes and that heme binding induces a conformational
change in Mss51. In-gel assessment of heme-associated perox-
idase activity (heme staining) efficiently detected the heme
bound to Mss51 in both denaturing and nondenaturing condi-
tions (Figure 1E). Even boiling of Mss51 for 30 min in 2% SDS
and/or 6M urea failed to remove heme from the polypeptide (Fig-
ure S1E). This result indicates that heme binding to Mss51 is
resistant to denaturing conditions that typically destroy the non-
covalent heme B-protein interactions therefore suggesting tight
binding.
The Integrity of the CPX Motifs Is Necessary for Full
Mss51 Function In Vivo
To assess the relevance of the CPX motifs for Mss51 function
in vivo, we engineeredDmss51 yeast strains expressing cysteine
to serine mutant forms of Mss51 from integrative or multicopy
plasmids. Additional strains were generated to express Mss51
variants in which the CPX cysteines were substituted by histi-
dines (C85H, C96H, and C85HC96H), a potential alternative
residue for heme coordination.
The C85S andC96Smutations did not affect the stability of the
mutant proteins in mitochondria and, when expressed from
single-copy integrants, accumulated at wild-type steady-state
levels. For the double mutant C85SC96S, protein levels were
unexpectedly 2-fold higher (Figure 2A). The three Cys to His vari-
ants accumulated at lower steady-state levels than the Cys
to Ser variants (Figure 2A). The overall stability of all these
proteins in mitochondria allowed us to characterize the resulting
phenotypes.
C85SMss51 largely complemented the respiratory growth
defect of the Dmss51 strain, whereas C96SMss51 did not
support respiration or did very poorly (Figure 2B). The entire
set of mutations affected COX activity in a manner consistent
with the respiratory growth phenotypes of the mutants (Fig-
ure 2C). As previously reported,50% of COX activity is enough
to support wild-type growth in complete respiratory media (Horn
et al., 2008). In all mutant strains, the steady-state levels of the
COX catalytic core subunits were decreased (Figure 2A), consis-
tently with their residual COX activity. The HPX variants were less
effective than the Ser variants in complementing the respiratory
growth and COX defects of the Dmss51 strain. This can be
explained by the lower steady-state levels of the C85H, C96H,
and C85HC96H Mss51 proteins detected in mitochondria (Fig-
ure 2A). Independently, our results indicate that although the
cysteines in the two CPX motifs are required for full Mss51 func-
tion in vivo, modifications of C96 within the second CPX motif
produced a more profound phenotype. The fact that Pro to Ser
changes in either or both CPXmotifs did not alter Mss51 function
(data not shown) indicates that the cysteines are the critical resi-
dues within these motifs.
To determine whether the CPX mutations affect the ability
of Mss51 to activate COX1 mRNA translation, we performed
in vivo mitochondrial protein synthesis assays. Pulses of 30 min
showed Cox1 synthesis to be mildly attenuated in the C85S
mutant compared to wild-type levels, more dramatically
decreased in the C96S mutant, and very poor but detectable in
the double mutant C85SC96S (Figure 2D). In the C85H and
C96H mutants, Cox1 synthesis was significantly more attenu-804 Cell Metabolism 16, 801–813, December 5, 2012 ª2012 Elsevierated than in the serine mutants (Figure 2D), most probably as
a result of the lower steady-state levels of the corresponding
Mss51 variants in mitochondria as stated earlier. Consistent
with this possibility, overexpression of all the single variants,
including the C85H and C96H mutants, significantly improved
Cox1 synthesis and respiratory growth (Figure S2). When ex-
pressed in single copy, the effects of the C85S and C96S vari-
ants on Cox1 synthesis are better appreciated in time course
pulse-labeling experiments presented in Figures 2E and 2F.
Cox1 synthesis in the strain expressingC85Sproceeds at a lower
rate than in wild-type cells (Figure 2E). Synthesis of Cox1 in the
C96S mutant proceeds at an even lower rate (Figure 2F), and
only some traces of radiolabeled Cox1 were detected in the
C96H mutant (Figure 2F). For the C85S and C85H mutants, we
assessed the stability of the newly synthesized Cox1 by pulse
chase. The amount of labeled Cox1 detected in these mutants
was as stable as in the wild-type strain but Cox2 and Cox3 are
less stable, presumably because COX assembly is compro-
mised in these strains (Figure 2G).
To test whether the decrease in Cox1 synthesis we observed
in the cysteine mutants of Mss51 CPX motifs is directly due to
a defect in translation and not the result of Cox1 synthesis down-
regulation, we introduced a Dcox14 mutation in the strains ex-
pressing a single copy of the C85S, C96S, and C85SC96S
mutant variants. In most COX assembly mutants, the absence
of Cox14 destabilizes the complex of sequestered Mss51 with
newly synthesized Cox1 and renders Mss51 available for trans-
lation, thus bypassing the feedback regulatory mechanism
(Barrientos et al., 2004). As shown in Figure 2H, the absence of
Cox14 did not alter the stability of the Mss51 variants. However,
Dcox14 did not restore Cox1 synthesis in any of the mutant
strains, and it was even detrimental for the strain expressing
the C85S variant (Figures 2H–2J). These results suggest that
the absence of either cysteine decreases Mss51 stimulation of
Cox1 translation, although the strain expressing the C85S muta-
tion produces enough Cox1 to support respiratory growth.
In a wild-type strain, Mss51 mostly accumulates in a 450 kDa
Cox1 preassembly complex that contains newly synthesized
Cox1, as well as other proteins such as Cox14, Cox25/Coa3,
and Ssc1 (Barrientos et al., 2004; Fontanesi et al., 2011; Mick
et al., 2010), although a small portion of Mss51 is also detected
in a 120 kDa heterodimer with Ssc1 (Fontanesi et al., 2010). By
sucrose gradient sedimentation analyses of mitochondrial
extracts, we detected the C85S, C96S, and C85SC96S Mss51
variants mostly in the 120 kDa complex (Figure 2K). A small
portion of each variant was detected in the 450 kDa complex,
consistent with the residual amount of Cox1 synthesis retained
in the mutant strains. Unexpectedly, in the absence of Cox14,
some C85S was trapped in the high molecular mass complex
thus explaining the poor Cox1 synthesis in this strain (Figure 2K).
Mss51 Binds Heme B In Vivo
To investigate whether Mss51 binds heme in vivo, we used
a strain that expresses a fully functional C-terminal GST-tagged
version of the protein (Barrientos et al., 2004). We generated
additional strains expressing a single copy or overexpressing
each of the Mss51 CPX variants. The Mss51-GST-tagged
C85S and C96S variants were less stable than the wild-type
protein but they accumulated when overexpressed (Figure S3A),Inc.
Figure 2. Mutations in Mss51 CPX Motifs
Affect Cox1 Synthesis and Assembly
(A) Immunoblot analyses of the steady-state levels
of Mss51 and COX catalytic core subunits in
a wild-type strain (W303) and a Dmss51 strain
expressing the indicated wild-type or CPX mutant
variants of Mss51.
(B) Growth test using serial dilutions of the
indicated strains in complete media containing
fermentable (glucose, YPD) or nonfermentable
(ethanol-glycerol, YPEG) carbon sources. The
plates were incubated at 30C, and the pictures
were taken after 2 days of growth.
(C) Cytochrome c oxidase (COX) activity mea-
sured spectrophotometrically in the indicated
strains. Error bars represent the mean ± SD.
(D–J) In vivo mitochondrial protein synthesis in the
indicated strains. Pulses were of 30 min (in D and
H) or the indicated times. In (G), after a 15 min
pulse, labeling was terminated by addition of
12 mg/ml puromycin + 80 mM nonradioactive
methionine, and the products were chased during
the indicated times. The signals were quantified as
in Figure 1B and used to plot the graphs in the
lower panels.
(K) Sucrose gradient sedimentation analyses of
Mss51 in mitochondrial extracts prepared from
the indicated strains. Fractions that containMss51
complex peaks are indicated. The gradients were
calibrated with lactate dehydrogenase (LDH,
130 kDa) and hemoglobin (Hb, 67 kDa).
See also Figure S2.
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Figure 3. Mitochondrial Mss51 Binds
Heme B
(A) Sucrose gradient sedimentation analyses of
Mss51 in mitochondrial extracts prepared from
the indicated strains. The indicated fractions
containing Mss51 complex peaks were used for
GST pull-down purification of the complexes.
(B) Hemes were extracted from 450 kDa and
120 kDa Mss51-containing complexes purified
from the indicated strains and analyzed by HPLC
on a reverse phase C18 column. The peaks cor-
responding to heme B (B) are marked. The peak
labeled * has not been identified but in some
repetitions also appeared in the blank and could
be part of the background. The amounts of heme
Bwere calculated from the areas under the peaks.
See also Figure S3.
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mented the respiratory growth of the Dmss51 strain as the
untagged versions of these proteins (Figure S3C).
The wild-type Mss51 and C85S, C96S, and C85SC96S GST-
tagged proteins were extracted from isolated mitochondria
and separated by sucrose gradient sedimentation as described
earlier. The pattern of native complexes was similar to that
observed in the strains expressing the untagged proteins (Fig-
ure 3A), although, in general, more Mss51 accumulated in the
120 kDa complex, which is typical of strains overexpressing
the protein (Fontanesi et al., 2010). The 450 kDa and 120 KDa
Mss51-GST-containing complexes were purified from each
strain and the amount of Mss51 estimated by immunoblotting
with a standard curve constructed with recombinant protein
(data not shown) as reported (Fontanesi et al., 2010). Approxi-
mately 0.2 mg Mss51 in the 450 kDa complex and 1.2 mg
Mss51 in the 120 kDa complex purified from each strain were
concentrated and treated with 250 mM HCl acetone for heme
extraction and high-performance liquid chromatography
(HPLC) analysis. We detected heme B (elution 10.8 min) in
both the 450 kDa and 120 kDa complexes purified from mito-
chondria expressing wild-type Mss51-GST. The fact that we
were able to detect heme in the organic solvent after extraction
with acidic acetone indicates that heme is not covalently bound
to mitochondrial Mss51 (Fuhrhop and Smith, 1975). No traces of
heme A (elution time 29 min, not shown in the graphs) were de-
tected. As a negative control, no traces of heme were detected806 Cell Metabolism 16, 801–813, December 5, 2012 ª2012 Elsevier Inc.when mitochondria expressing untagged
Mss51 were used. This result supports
that the heme B content in Mss51-GST-
containing complexes is specific to the
presence of Mss51, and not the result of
a nonspecific interaction of heme with
the glutathione beads.
The identification of heme B as the
species binding to Mss51 in vivo does
not support a role for Mss51 in handling
heme A for insertion into newly synthe-
sized Cox1. Furthermore, the absence
of heme A in the 450 kDa complex
suggests that the Cox1 protein is not he-mylated, in agreement with recent observations (Bestwick
et al., 2010). This result indicates that Cox1 hemylation does
not occur cotranslationally and that it is not required for Cox1
stability in the Mss51-containing preassembly complex as re-
ported (Khalimonchuk et al., 2010). The presence of heme B in
both complexes suggests that this moiety is necessary for
Mss51 functions at different steps of Cox1 biogenesis.
The 120 kDa complexes purified from the strains expressing
the partially functional C85S-GST and C96S-GST variants con-
tained an amount of heme B 5- to 7-fold lower than the wild-
type complexes (Figure 3B), in agreement with the limited ability
of these mutant proteins to bind hemin in vitro. In most 450 kDa
complex preparations analyzed, the amounts of heme were
below the detection limits (Figure 3B), and only traces were de-
tected in one out of three preparations containing C85S-GST
(data not shown). Interestingly, we detected a significant amount
of heme B in the complexes containing the nonfunctional
double-mutant C85SC96S-GST protein, particularly in the
more abundant 120 kDa complex. This observation is consistent
with the in vitro data suggesting unspecific heme binding to the
double-mutant protein.
Quantitative analysis of the HPLC data allowed us to estimate
a Mss51/heme molecular ratio 3:1 in the wild-type 450 kDa
Mss51 complex and 7:1 in the 120 kDa complex. Although
our results clearly show the presence of heme in these
complexes, the quantitative results could be underestimated if
in vivo some heme interacts weakly or transiently with Mss51.
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To further investigate the role of heme in regulating Cox1
synthesis, we analyzed a strain carrying a null mutation in
HEM1 that encodes the 5-aminolevulinate acid synthase, a
protein located in the mitochondrial matrix, where it catalyzes
the first step in heme biosynthesis. A Dhem1 strain can only
survive in fermentable media supplemented with a source of
oleic acid (Tween 80), ergosterol, and methionine (TEM), whose
biosynthesis is mediated by hemoproteins (Gollub et al., 1977).
In contrast, the Dhem1 strain recovers respiratory capacity
when grown in the presence of a heme precursor such as amino-
levulinic acid (ALA) to support heme synthesis. The mutant
phenotype can be induced in TEM-containing medium by
depriving the cells of ALA for 16 hr, at which time heme levels
were barely detectable (less than 1% as detected in mitochon-
drial extracts by HPLC) compared to the cells grown in ALA-sup-
plemented medium (Figure S4). Heme depletion readily affected
the accumulation of heme-containing proteins such as Cox1
(Figure 4A) and cytochrome b2, expression of which is transcrip-
tionally controlled by the heme-dependent regulator Hap1 and
by the HAP transcriptional complex (Lodi and Guiard, 1991).
However, MSS51 expression is not regulated by the HAP
complex (Fontanesi et al., 2008), and Mss51 levels were similar
in heme-containing and heme-depleted wild-type and Dcox14
cells (Figure 4A). As an independent approach to deplete heme
we exposed wild-type cells to the heme synthesis inhibitor 4,6-
dioxoheptanoic acid (DHA) in the presence of TEM for 14 hr. After
this treatment, Cox1 and cytochrome b2 failed to accumulate,
but Mss51 levels remained unchanged (Figure 4B). These results
indicate that in the absence of heme, Mss51 steady-state levels
remain stable.
Sucrose gradient sedimentation analyses of Mss51 extracted
from the Dhem1 strain grown in the presence of ALA showed
a wild-type Mss51 distribution, with most Mss51 in the 450 kDa
complex and approximately 10% in the 120 kDa complex (Fig-
ure 4C). Mss51 extracted from the Dhem1 strain grown in the
presence of TEM accumulated exclusively in the 450 kDa
complex. This is consistent with the lack of heme A as observed
in Cox1 hemylation mutants, although in these mutants Mss51
additionally accumulates complexed with the COX1 mRNA
translational machinery (Fontanesi et al., 2010). Mss51 extracted
from the Dhem1Dcox14 strain showed a similar pattern when
grown in the presence of ALA or TEM, with all Mss51 accumu-
lated in the 120 kDa complex. In conclusion, the absence of
heme fromMss51does not alter the stability ofMss51or its accu-
mulation within high molecular mass complexes.
Cox1 Synthesis Is Attenuated in Heme-Depleted Cells
To explore whether the absence of heme fromMss51 affects the
function of Mss51, we performed in vivo mitochondrial protein
synthesis analyses in Dhem1 strains. Detection of [35S]-methio-
nine accumulation into newly synthesized Cox1 and cytochrome
b was strongly attenuated in heme-depleted Dhem1 cells (Fig-
ure 4D). The poor Cox1 synthesis is not the result of translational
downregulation due to a COX assembly defect but rather is
predominantly due to a specific Cox1 translational defect in
the absence of heme, because Cox1 synthesis recovered only
partially in heme-depleted Dhem1 cells expressing an additional
Dcox14 mutation (Figure 4D).Cell MAs for the Dhem1 mutant, DHA-treated wild-type cells dis-
played a significant attenuation on [35S-methionine] incorpora-
tion into newly synthesized Cox1 and cytochrome b, which in
the case of Cox1 was only partially restored in the absence of
Cox14 (Figure 4E). Whether cytochrome b synthesis is downre-
gulated in the absence of heme or its turnover is enhanced in
the absence of its prosthetic group is an open question out of
the scope of this manuscript.
In the case of Cox1, to further distinguish between synthesis
defect and increased turnover, we treated with DHA a strain
carrying a reporter gene forCOX1mRNA translation. The system
is based on the insertion of a recoded version of the nuclear gene
ARG8 into themtDNA of aDarg8 strain (Steele et al., 1996). Mito-
chondrial ARG8 expression in the Darg8 strain confers arginine
prototrophy. We used the strain XPM78a (Perez-Martinez
et al., 2003), in which expression of ARG8 fused to COX1 was
placed under the control of the COX1 50 UTR (Figure 5A) and
the derivative strain LSR39, which carries an additional Dcox14
mutation (Shingu´-Va´zquez et al., 2010). It is known that after
synthesis, the Cox1-Arg8 fusion protein is cleaved and the two
proteins are functional (Steele et al., 1996). In both DHA-treated
XPM78a and LRS39 cells, synthesis of the fusion protein was
significantly decreased (Figure 5A). DHA-treated XPM78a and
LRS39 cells failed to grow robustly in fermentable media lack-
ing arginine (Figure 5A). Because arginine-dependent growth
reports COX1 mRNA translation, such results strongly support
a direct heme-dependent regulation of Cox1 synthesis, presum-
ably by amechanism based on inhibition of the translational acti-
vation activity of Mss51 when the protein does not bind heme.
Several mechanisms known to bypass feedback regulation of
COX1 mRNA translation also failed to induce total recovery of
Cox1 synthesis, albeit that at different degrees, in heme-
depleted cells. This was true for strains carrying an additional
copy of wild-type MSS51 (Figure 5B). And for strains with
increased amounts of Mss51 available for translation because
Mss51 sequestration in the 450 kDa complex is prevented,
such as in strains expressing a C-terminal truncated form of
Cox1 (strain TFL269) (Shingu´-Va´zquez et al., 2010) (Figure 5C)
or a Dcox25/coa3mutation (Figure 6A). These results confirmed
that although some of the Cox1 synthesis defect observed upon
heme depletion is probably downregulation of its translation due
to defective COX assembly, the absence of heme from Mss51
causes an additional robust decrease in COX1 mRNA transla-
tion. Only Mss51 overexpression supported Cox1 synthesis in
heme-depleted cells (Figure 5B). Overall, these results are
compatible with the view that Mss51 can perform its role in
COX1 mRNA translation with low levels of heme, but heme is
necessary in order to accomplish this function efficiently.
We predicted that the C85S mutant that binds heme only
poorly (Figure 3B) yet sustains 60% of Cox1 synthesis (Fig-
ure 2E) should be less sensitive to heme depletion. The results
presented in Figure 5D are compatible with this prediction and
further underscore the role of CPX motifs in heme binding.
Mutations in Mss51 Suppress the Sensitivity of Cox1
Synthesis to Heme Depletion
We previously reported that a single copy of the mutant alleles
mss51T167R and mss51F199I or additional copies of wild-type
MSS51 partially suppress the respiratory defect of mutants ofetabolism 16, 801–813, December 5, 2012 ª2012 Elsevier Inc. 807
Figure 4. Heme Is Not Required for Mss51 Stability but for Mss51 Function
(A) Immunoblot analyses of the steady-state levels of Mss51, Cytochrome b2, and Cox1 in Dhem1 and Dhem1Dcox14 strains grown in the presence of ALA or
TEM. The signals were quantified as in Figure 1B, normalized to porin signal, and plotted in the lower panel.
(B) Same as in 4A but here a wild-type strain (W303) was treated with the heme biosynthesis inhibitor DHA at the indicated concentrations and periods of time in
the presence of TEM. The signals were quantified as in Figure 1B and plotted in the lower panels.
(C) Sucrose gradient sedimentation analyses of Mss51 in mitochondrial extracts prepared from the indicated strains as in Figure 2I.
(D and E) In vivo mitochondrial protein synthesis in the indicated strains and growth conditions performed as in Figure 2D. The signals were quantified as in
Figure 1B and used to plot the graphs in the lower panels.
See also Figure S4.
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Heme-Mediated Mitochondrial Translational ControlSHY1, a COX assembly factor, by increasing Cox1 synthesis
(Barrientos et al., 2002). In most COX-deficient strains, mutant
or additional copies of MSS51 do not suppress the COX808 Cell Metabolism 16, 801–813, December 5, 2012 ª2012 Elsevierassembly defect but significantly increase Cox1 synthesis
bypassing the negative feedback regulation (Barrientos et al.,
2004). We have proposed that the suppression of the COX1Inc.
Figure 5. Heme Is Required for Efficient
COX1 mRNA Translation
(A) In vivo mitochondrial protein synthesis in the
indicated strains treated or not with DHA. The
wild-type (XPM78a) and Dcox14 (LSR39) strains
carry an engineered COX1-ARG8 reporter gene in
their mitochondrial DNA (upper panel). The
synthesized Cox1-Arg8 fusion protein is indicated.
The lower panel shows a serial dilution growth test
of the strains in synthetic media supplemented or
not with DHA and arginine.
(B–D) In vivo mitochondrial protein synthesis in the
indicated strains treated or not with DHA. The
signals were quantified as in Figure 1B and used to
plot the graphs in the lower panels.
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Heme-Mediated Mitochondrial Translational ControlmRNA translation defect byMss51T167R andMss51F199I is due to
their increased intrinsic capacity to avoid the trap within the
450 kDa complex and to accumulate mainly in the 120 kDa
complex with Ssc1, the complex that serves as a reservoir for
translationally competent Mss51 (Fontanesi et al., 2010).
Notably, expression of the T167R or F199I variants of Mss51
fully suppressed any sensitivity of Cox1 synthesis to DHA-
induced heme depletion either when expressed in a wild-type
or aDmss51 strain (Figures 6A–6C). Similarly, aDhem1 strain ex-
pressing Mss51T167R efficiently synthesized Cox1 both when
grown in the presence of ALA or TEM (Figure 6D). As expected,
newly synthesizedCox1 in these strains grown in the presence of
DHA is as unstable as in a Dcox14 strain (Figure 6E). This is dueCell Metabolism 16, 801–813,to the lack of Cox1 hemylation and COX
assembly in the absence of heme. A
GST-tagged version of mss51F199I fully
complemented a Dmss51 strain (Fig-
ure S5A) and was used to purify the
450 kDa and the 120 kDaMss51-contain-
ing complexes (Figure S5B). HPLC anal-
yses detected only traces of heme B in
the 120 kDa complex (Figure S5C). The
distribution of Mss51F199I in the 450 kDa
and 120 kDa complexes was similar in
the presence and absence of heme,
although in heme depleted cells more
Mss51 was detected in the 450 kDa
complex and in higher molecular mass
material (Figure 6F) as reported in Cox1
hemylation mutants (Fontanesi et al.,
2010). Altogether, the observations pre-
sented here strongly link Mss51 to heme
sensing and heme-mediated regulation
of COX1 mRNA translation.
DISCUSSION
Although heme has been shown to play
roles in regulation of nuclear gene
expression (both transcription and trans-
lation), the possible role/s of heme in
regulatingmitochondrial gene expressionare largely unexplored. Here we report a regulatory mechanism
by which the function of the mitochondrial COX1mRNA transla-
tional activator Mss51 is regulated by heme. The N terminus of
Mss51 contains two heme-responsive CPX motifs. Our in vivo
and in vitro data strongly support a role of these motifs in
heme binding to Mss51. Mss51 is the central element of an
autofeedback translational repression mechanism in mitochon-
dria that couples Cox1 synthesis with its assembly in COX (Fig-
ure 7). These findings significantly enrich our understanding of
the physiological role of Mss51 in the regulation of COX biogen-
esis and aerobic energy production by revealing an additional
level of mitochondrial translational regulation involving heme
sensing.December 5, 2012 ª2012 Elsevier Inc. 809
Figure 6. Mss51 Mutants Bypass the Require-
ment of Heme for EfficientCOX1mRNATransla-
tion
(A–E) In vivo mitochondrial protein synthesis in the
indicated strains treated or not with DHA in the pres-
ence of TEM or, in (D), the Dhem1, mss51T167R strain
incubated in the presence of either ALA or TEM. In (E),
after a 10 min pulse, the labeled proteins were chased
for 30 and 60 min. The signals were quantified as in
Figure 1B and used to plot the graphs in the lower or
side panels.
(F) Sucrose gradient sedimentation analyses of GST-
tagged Mss51F199I in mitochondrial extracts prepared
from the indicated strains as in 2I.
See also Figure S5.
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Figure 7. Model of Heme Sensing by Mss51 to Coordinate Cox1
Translation and Assembly
See the explanation in the Discussion.
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Heme-Mediated Mitochondrial Translational ControlThe observation that Mss51 binds heme B involving CPX
motifs suggested heme could play a regulatory role in Mss51
functions. CPX motifs generally participate in transient heme
binding to proteins and are known to control processes related
to iron and oxidative metabolism in prokaryotes and eukaryotes
(Mense and Zhang, 2006). For example, in S. cerevisiae, heme
synthesis is regulated in response to oxygen levels (Hon et al.,
2003). The heme activator protein Hap1 binds heme through
CPX motifs and functions either as a transcriptional repressor
or activator, depending on heme levels, thus mediating oxygen
sensing and heme signaling (Zhang and Guarente, 1995). In
mammals, CPX motifs are present, for example, in the transcrip-
tional repressor Bach1, that regulates globin expression, and in
the HRI kinase, which coordinates globin protein synthesis and
heme availability in reticulocytes (Mense and Zhang, 2006).
With few exceptions, the molecular mechanisms of the ‘‘heme-
regulated’’ proteins remain unclear due to the lack of their
structural characterizations. In the bacterium Bradyrhizobium
japonicum, the iron response regulator (Irr) mediates the iron-
dependent transcriptional regulation of heme synthesis (Mense
and Zhang, 2006) through heme binding to two sites, one of
them consisting of the cysteine in a CPX motif (Ishikawa et al.,
2011). In the case of the mammalian Rev-erbb, a heme-binding
nuclear hormone receptor that represses a broad spectrum of
target genes involved in regulating metabolism and the circadian
cycle, a thiol/disulfide redox switch involving the cysteines in two
CPX motifs controls heme binding and dissociation (Gupta and
Ragsdale, 2011). In this case, heme iron is hexacoordinated by
a CPX motif Cys and a His residue. The difference absorptionCell Mspectra of heme-reconstituted recombinant Rev-erbb display
a profile with Soret peak at 416 and a and b peaks at 537 and
567, respectively. Upon oxidation of the sulfhydryl to a disulfide,
heme coordination switches and the binding affinity decreases
(Gupta and Ragsdale, 2011). Heme coordination by Mss51
somehow resembles that of Rev-erbb. The difference spectra
revealed a Soret band at 416 nm and in the a and b bands at
550 and 520 nm, respectively. We were able to extract heme B
frommitochondrial Mss51 using acidic acetone, which indicates
noncovalent heme binding to the polypeptide. However, heme
binding to recombinant Mss51 was resistant to denaturing
conditions such as 2%SDS and 6M urea, which points to a tight
interaction between Mss51 and heme as previously reported for
other proteins (Lechardeur et al., 2010). InMss51, the absence of
C96 in the second CPXmotif affects more severely heme binding
and Mss51 function in vivo than the absence of C85 in the first
CPX motif. The protein contains three additional cysteines (Fig-
ure 1), mutation of each to serine does not affect respiratory
growth (data not shown). The identification of the residues
directly involved in the heme coordination is the focus of ongoing
efforts in our laboratory.
For most heme-regulated proteins, in vivo heme binding has
not been demonstrated. This is not a trivial task given the tran-
sient interaction most of these proteins are predicted to have
with heme. We have been able to detect heme B in Mss51 puri-
fied within physiological high-molecular mass complexes iso-
lated from mitochondria and to correlate heme binding and
Mss51 function to the integrity of the CPXmotifs. It is remarkable
that Mss51 associates with the mitochondrial Hsp70 chaperone
Ssc1 (Fontanesi et al., 2010) in a manner similar to other heme-
regulated proteins that also interact with multichaperone
complexes containing Hsp70 and Hsp90. In yeast Hap1, CPX
motifs arbitrate heme-dependent formation of protein com-
plexes with Hsp70 and 90 chaperones that allow Hap1 to bind
DNA and activate transcription (Lan et al., 2004). In mammals,
the HRI kinase also associates with Hsp70 and 90 chaperones
to mediate heme-regulated translation inhibition and provide
one major mechanism that ensures balanced synthesis of
globins and heme as stated earlier (Mense and Zhang, 2006).
Regulatory heme binding and release from Mss51 and other
heme-regulated proteins would be expected to induce confor-
mational changes in the protein that could be facilitated by their
interacting chaperones.
Heme binding is not essential for Mss51 stability in vivo, but it
does regulate its function as a COX1 mRNA translational acti-
vator. Several pieces of information support this conclusion: (1)
translation of an ARG8 reporter gene placed under the control
of theCOX1 promoter is dependent on heme; (2) Cox1 synthesis
requires heme, even in strains in which the negative feedback
translational regulation exerted by Mss51 is suppressed, namely
strains carrying mutations in cox14, cox25/coa3 or expressing
a C-terminal truncation in Cox1; (3) Cox1 synthesis is attenuated
in CPX mutant strains, particularly those expressing C96 vari-
ants; (4) Cox1 synthesis in a strain expressing C85S is less sensi-
tive to heme depletion; and (5) some mutant forms of Mss51,
namely the T167R and F199I mutations, render the protein
completely insensitive to heme regulation. This collection of
observations strongly links both the CPX motifs in Mss51 to
heme binding and the Mss51-heme binding to regulation ofetabolism 16, 801–813, December 5, 2012 ª2012 Elsevier Inc. 811
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Heme-Mediated Mitochondrial Translational ControlCOX1mRNA translation. Whether Mss51 requires heme binding
to adopt the proper conformation that allows for efficient interac-
tion with the COX1mRNA and what is the contribution of Ssc1 in
this process are outstanding questions that warrant future
investigation.
The translational regulatory system described here was
believed to be restricted to fungi because (1) Mammalian mito-
chondrial mRNAs lack 50 UTR and how translation is activated
in mammalian mitochondria remains to be understood and (2)
orthologs of Mss51, Cox14, and Cox25 have not been identified.
However, mutations in proteins with similarity to Cox14
(C12Orf62) and Cox25 (CCDC56) have been recently recognized
to cause COX-specific defects in humans and fly (Peralta et al.,
2012; Weraarpachai et al., 2012). Although no clear Mss51
ortholog is encoded in mammalian genomes, the mammalian
MSS51/ZMYND17 protein exhibits significant similarity (Szklarc-
zyk et al., 2012). ZMYND17 contains a zinc finger domain formed
by cysteines that in alignments with yeastMss51 overlapwith the
CPX motifs cysteines (Figure S6). The ability of the human
protein to bind heme and its hypothetical role in COX assembly
are of high biological and biomedical interest and also warrant
future investigation.
In conclusion, S. cerevisiae Mss51 is the first heme-binding
protein described to play a role in mitochondrial translational
activation. By binding heme B, Mss51 could sense oxygen levels
(required for heme biosynthesis) and heme availability for heme
A biosynthesis (Figure 7) tomodulate Cox1 synthesis and subse-
quent assembly into COX, the major oxygen-consuming mito-
chondrial enzyme, essential for aerobic ATP production. Finally,
on the light of the mechanism uncovered here, it is tempting to
speculate that heme B could serve as a more general sensing
element capable of activating not only COX assembly but also
the biogenesis of other cytochrome-containing respiratory chain
components.
EXPERIMENTAL PROCEDURES
Yeast Strains and Media
All S. cerevisiae strains used are listed in Table S1, and the composition of the
standard culture media used is defined in the Supplemental Experimental
Procedures.
In Vivo Mitochondrial Protein Synthesis
Mitochondrial gene products were labeled with [35S]-methionine (7 mCi/mmol,
Perkin Elmer) in whole cells at 30C in the presence of 0.2 mg/ml cyclohexi-
mide to inhibit cytoplasmic protein synthesis (Barrientos et al., 2002). Equiva-
lent amounts of total cellular proteins were separated by SDS-PAGE on
a 17.5% polyacrylamide gel, transferred to a nitrocellulose membrane, and
exposed to Kodak X-OMAT X-ray film.
Purification of Wild-Type and CPX Mutant Variants of Mss51
Wild-type and Mss51 CPX mutant versions fused to a thrombin-cleavable
trigger factor tag (TF-Mss51,TF-Mss51C85S, TF-Mss51C96S, TF-Mss51C85SC96S)
were expressed as His6-tagged proteins from the pColdTF vector (Genescript)
in the BL21 Star protein expression strain of E. coli (Invitrogen, Carlsbad, CA),
extracted and purified by metal affinity using a Cobalt Sepharose HiTrap HP
affinity column (Amersham) as described in the Supplemental Experimental
Procedures.
Spectrophotometric Properties of Heme-Titrated Recombinant
Mss51
Heme titrations were performed by difference spectroscopy aerobically and at
room temperature with a double-beam UV-2401PC Shimadzu spectropho-812 Cell Metabolism 16, 801–813, December 5, 2012 ª2012 Elseviertometer as described (Gupta and Ragsdale, 2011) and are fully explained in
the Supplemental Experimental Procedures. For determination of the binding
parameters, the data obtained from the heme titrations were plotted and fit to
an equation describing a single site binding (Y =BmaxX=Kd +X) with the
GraphPad Prism software.
Heme Content Determination in Mitochondrial Mss51-Containing
Complexes
To obtain material for heme content determination by HPLC, we extracted
30 mg mitochondria purified from strains expressing GST-tagged versions
of Mss51, sedimented the extracts in multiple sucrose gradients, pooled the
three fractions around the 120 kDa and 450 kDa peaks, and performed GST
pull-down assays as described (Fontanesi et al., 2010) and explained in the
Supplemental Experimental Procedures. The pull-down elutes were concen-
trated with Vivaspin 500 columns (Sartorius Stedim Biotech, Germany) and
extracted with 250 mM HCl acetone and 50% acetonitrile, and the samples
were analyzed with a C18 column as described (Barros and Tzagoloff,
2002). The amount of Mss51 in each sample was estimated for each experi-
ment by immunoblotting with a standard curve generated with purified
recombinant protein as detailed (Fontanesi et al., 2010). Heme concentration
(mM) was calculated with the absorbance maxima at 10.8 min of elution and
an extinction coefficient of 180 mM1 3 cm1 at 400 nm.
Miscellaneous Procedures
In vitroMss51-heme binding assays were performedwith purified proteins and
hemin-conjugated agarose beads (Sigma). The heme-associated peroxidase
activity (heme staining) of PAGE-separated heme-bound Mss51 was revealed
directly in-gel by the enhanced chemiluminescence method from Pierce
(Supersignal Femto). Purification of mitochondria from yeast strains and mito-
chondrial respiratory chain enzymatic measurements were performed as
reported (Barrientos et al., 2002). All miscellaneous methods are detailed in
the Supplemental Experimental Procedures.
Statistical Analysis
All experiments were done at least in triplicate. All data are presented as
means ± SD of absolute values or percent of control. Values were analyzed
for statistical significance by Student’s t test. p < 0.05 was considered
significant.SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
six figures, and one table and can be found with this article online at http://
dx.doi.org/10.1016/j.cmet.2012.10.018.
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